Celecoxib in cancer therapy and prevention–review

N Tołoczko-Iwaniuk… - Current Drug …, 2019 - ingentaconnect.com
Background and Objectives: It is generally accepted that inflammatory cells found in the
tumor microenvironment are involved in the neoplastic process, promoting cell proliferation …

Targeting the redox imbalance in mitochondria: A novel mode for cancer therapy

S Mani, G Swargiary, SJ Ralph - Mitochondrion, 2022 - Elsevier
Abstract Changes in reactive oxygen species (ROS) levels affect many aspects of cell
behavior. During carcinogenesis, moderate ROS production modifies gene expression to …

Celecoxib repurposing in cancer therapy: molecular mechanisms and nanomedicine-based delivery technologies

AF Khafaga, RN Shamma, A Abdeen, AM Barakat… - …, 2021 - Taylor & Francis
While cancer remains a significant global health problem, advances in cancer biology, deep
understanding of its underlaying mechanism and identification of specific molecular targets …

High ROS production by celecoxib and enhanced sensitivity for death ligand-induced apoptosis in cutaneous SCC cell lines

J Zhu, S May, C Ulrich, E Stockfleth… - International Journal of …, 2021 - mdpi.com
Incidence of cutaneous squamous cell carcinoma (cSCC) and actinic keratosis has
increased worldwide, and non-steroidal anti-inflammatory drugs as celecoxib are …

[HTML][HTML] IL10-modified human mesenchymal stem cells inhibit pancreatic cancer growth through angiogenesis inhibition

C Zhao, Y Pu, H Zhang, X Hu, R Zhang, S He… - Journal of …, 2020 - ncbi.nlm.nih.gov
In the present study, we constructed the recombinant plasmid IL10-PEGFP-C1 and
successfully transfected into human mesenchymal stem cells. After culturing for 72 h, the …

Selenium-based novel epigenetic regulators offer effective chemotherapeutic alternative with wider safety margins in experimental colorectal cancer

P Ghanghas, M Sharma, D Desai, K Raza… - … Trace Element Research, 2022 - Springer
Colorectal cancer (CRC) is a major cause of morbidity and mortality worldwide. Despite the
critical involvement of epigenetic modifications in CRC, the studies on the chemotherapeutic …

Diclofenac down-regulates COX-2 induced expression of CD44 and ICAM-1 in human HT29 colorectal cancer cells

Ç Yilmaz, S Köksoy, T Çeker, M Aslan - Naunyn-Schmiedeberg's archives …, 2021 - Springer
Abstract Cyclooxygenase-2 (COX-2) is expressed in a variety of human colorectal cancer
cells and can contribute to carcinogenesis. This study aimed to investigate the effect of …

[HTML][HTML] The molecular targets of diclofenac differs from ibuprofen to induce apoptosis and epithelial mesenchymal transition due to alternation on oxidative stress …

ED Arisan, RO Akar, O Rencuzogullari, PO Yerlikaya… - Prostate …, 2019 - Elsevier
Background Prostate cancer is the most common type of cancer among men. Studies
showed that the regular use of nonsteroidal antiinflammatory drugs might reduce disease …

Effect of a topical nonsteroidal anti-inflammatory drug (0.1% pranoprofen) on VEGF and COX-2 expression in primary pterygium

B Yao, F Wang, X Zhao, B Wang, X Yue… - Frontiers in …, 2021 - frontiersin.org
Purpose: To evaluate the effect of a topical nonsteroidal anti-inflammatory drug (0.1%
pranoprofen) on the expression of VEGF and Cox-2 in primary pterygium. Methods: This was …

[HTML][HTML] Cancer stem cells, stemness markers and selected drug targeting: metastatic colorectal cancer and cyclooxygenase-2/prostaglandin E2 connection to WNT as …

RA ALHulais, SJ Ralph - Journal of Cancer Metastasis and …, 2019 - oaepublish.com
Few studies have reported on the analyses of drugs targeting enriched populations of
cancer stem cells (CSCs) as a means for identifying potent anti-CSC agents. This review …